The linear-ordered collagen scaffold-BDNF complex significantly promotes functional recovery after completely transected spinal cord injury in canine

Biomaterials

Volumn 41, Issue , 2015, Pages 89-96

  Han, Sufang ^a   Wang, Bin ^a,b   Jin, Wei ^c   Xiao, Zhifeng ^a,d   Li, Xing ^a   Ding, Wenyong ^a   Kapur, Meghan ^b   Chen, Bing ^a,d   Yuan, Baoyu ^c   Zhu, Tiansheng ^c   Wang, Handong ^c   Wang, Jing ^c   Dong, Qun ^e   Liang, Weibang ^c   Dai, Jianwu ^a,d  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e St Joseph's Hospital   (United States)

Author keywords

Canine; CBD BDNF; Linear ordered collagen scaffold (LOCS); Regeneration; Spinal cord injury (SCI)

Indexed keywords

PATIENT REHABILITATION; RECOVERY; SCAFFOLDS;

CANINE; CBD-BDNF; COLLAGEN SCAFFOLDS; REGENERATION; SPINAL CORD INJURIES (SCI);

COLLAGEN;

BRAIN DERIVED NEUROTROPHIC FACTOR; COLLAGEN; COLLAGEN BINDING DOMAIN; HYBRID PROTEIN; LINEAR ORDERED COLLAGEN SCAFFOLD; MOLECULAR SCAFFOLD; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANINE MODEL; COLLAGEN FIBER; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HISTOLOGY; HUMAN; HUMAN CELL; LOCOMOTION; NERVE FIBER REGENERATION; NONHUMAN; REMYELINIZATION; SENSORY SYSTEM; SPINAL CORD INJURY; SPINE IMPLANT; ANIMAL; BOVINE; CHEMISTRY; CONVALESCENCE; DOG; DRUG EFFECTS; METABOLISM; MYELIN SHEATH; NERVE FIBER; NERVE REGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; SPINAL CORD INJURIES; TISSUE SCAFFOLD; ULTRASTRUCTURE;

CANIS FAMILIARIS;

ANIMALS; AXONS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATTLE; COLLAGEN; DOGS; HUMANS; MYELIN SHEATH; NERVE REGENERATION; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TISSUE SCAFFOLDS;

EID: 84916908595     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.11.031     Document Type: Article

References (38)

1. Thuret S., Moon L.D., Gage F.H. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006, 7:628-643.
2. Johnson P.J., Parker S.R., Sakiyama-Elbert S.E. Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. JBiomed Mater Res Part A 2010, 92:152-163.
3. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008, 209:294-301.
4. Fawcett J.W. Overcoming inhibition in the damaged spinal cord. JNeurotrauma 2006, 23:371-383.
5. Straley K.S., Foo C.W., Heilshorn S.C. Biomaterial design strategies for the treatment of spinal cord injuries. JNeurotrauma 2010, 27:1-19.
6. Maeda M., Tani S., Sano A., Fujioka K. Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs. JControlled Rel Off J Controlled Rel Soc 1999, 62:313-324.
7. Rocha L.B., Goissis G., Rossi M.A. Biocompatibility of anionic collagen matrix as scaffold for bone healing. Biomaterials 2002, 23:449-456.
8. Lin H., Chen B., Wang B., Zhao Y., Sun W., Dai J. Novel nerve guidance material prepared from bovine aponeurosis. JBiomed Mater Res Part A 2006, 79:591-598.
9. Blesch A., Lu P., Tuszynski M.H. Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull 2002, 57:833-838.
10. Pearse D.D., Bunge M.B. Designing cell- and gene-based regeneration strategies to repair the injured spinal cord. JNeurotrauma 2006, 23:438-452.
11. Nomura H., Tator C.H., Shoichet M.S. Bioengineered strategies for spinal cord repair. JNeurotrauma 2006, 23:496-507.
12. Weishaupt N., Blesch A., Fouad K.B.D.N.F. the career of a multifaceted neurotrophin in spinal cord injury. Exp Neurol 2012, 238:254-264.
13. Coumans J.V., Lin T.T., Dai H.N., MacArthur L., McAtee M., Nash C., et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. JNeurosci Off J Soc Neurosci 2001, 21:9334-9344.
14. Bamber N.I., Li H., Lu X., Oudega M., Aebischer P., Xu X.M. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci 2001, 13:257-268.
15. Sun W., Sun C., Lin H., Zhao H., Wang J., Ma H., et al. The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. Biomaterials 2009, 30:4649-4656.
16. Han Q., Jin W., Xiao Z., Ni H., Wang J., Kong J., et al. The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody. Biomaterials 2010, 31:9212-9220.
17. Han Q., Sun W., Lin H., Zhao W., Gao Y., Zhao Y., et al. Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A 2009, 15:2927-2935.
18. Olby N., Halling K.B., Glick T.R. Rehabilitation for the neurologic patient. Vet Clin North Am Small Anim Pract 2005, 35:1389-1409. viii.
19. Woerly S., Doan V.D., Sosa N., de Vellis J., Espinosa A. Reconstruction of the transected cat spinal cord following NeuroGel implantation: axonal tracing, immunohistochemical and ultrastructural studies. Int J Dev Neurosci Off J Int Soc Dev Neurosci 2001, 19:63-83.
20. Olby N.J., De Risio L., Munana K.R., Wosar M.A., Skeen T.M., Sharp N.J., et al. Development of a functional scoring system in dogs with acute spinal cord injuries. Am J Vet Res 2001, 62:1624-1628.
21. Lim J.H., Jung C.S., Byeon Y.E., Kim W.H., Yoon J.H., Kang K.S., et al. Establishment of a canine spinal cord injury model induced by epidural balloon compression. JVet Sci 2007, 8:89-94.
22. Park Y.M., Lee W.T., Bokara K.K., Seo S.K., Park S.H., Kim J.H., et al. The multifaceted effects of agmatine on functional recovery after spinal cord injury through modulations of BMP-2/4/7 expressions in neurons and glial cells. PLoS One 2013, 8:e53911.
23. Sharp K.G., Dickson A.R., Marchenko S.A., Yee K.M., Emery P.N., Laidmae I., et al. Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation. Exp Neurol 2012, 235:345-356.
24. Ding Y., Yan Q., Ruan J.W., Zhang Y.Q., Li W.J., Zhang Y.J., et al. Electro-acupuncture promotes survival, differentiation of the bone marrow mesenchymal stem cells as well as functional recovery in the spinal cord-transected rats. BMC Neurosci 2009, 10:35.
25. Xie J., Boakye M. Electrophysiological outcomes after spinal cord injury. Neurosurg Focus 2008, 25:E11.
26. Saruhashi Y., Young W., Perkins R. The recovery of 5-HT immunoreactivity in lumbosacral spinal cord and locomotor function after thoracic hemisection. Exp Neurol 1996, 139:203-213.
27. Yan Q., Ruan J.W., Ding Y., Li W.J., Li Y., Zeng Y.S. Electro-acupuncture promotes differentiation of mesenchymal stem cells, regeneration of nerve fibers and partial functional recovery after spinal cord injury. Exp Toxicol Pathol Off J Ges Toxikol Pathol 2011, 63:151-156.
28. Sasaki M., Li B., Lankford K.L., Radtke C., Kocsis J.D. Remyelination of the injured spinal cord. Prog Brain Res 2007, 161:419-433.
29. Bradbury E.J., McMahon S.B. Spinal cord repair strategies: why do they work?. Nat Rev Neurosci 2006, 7:644-653.
30. Akhtar A.Z., Pippin J.J., Sandusky C.B. Animal models in spinal cord injury: a review. Rev Neurosci 2008, 19:47-60.
31. Kwon B.K., Oxland T.R., Tetzlaff W. Animal models used in spinal cord regeneration research. Spine 2002, 27:1504-1510.
32. You S.W., Chen B.Y., Liu H.L., Lang B., Xia J.L., Jiao X.Y., et al. Spontaneous recovery of locomotion induced by remaining fibers after spinal cord transection in adult rats. Restor Neurol Neurosci 2003, 21:39-45.
33. Jung D.I., Ha J., Kang B.T., Kim J.W., Quan F.S., Lee J.H., et al. Acomparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. JNeurol Sci 2009, 285:67-77.
34. Lim J.H., Byeon Y.E., Ryu H.H., Jeong Y.H., Lee Y.W., Kim W.H., et al. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. JVet Sci 2007, 8:275-282.
35. Kim B.G., Kang Y.M., Phi J.H., Kim Y.H., Hwang D.H., Choi J.Y., et al. Implantation of polymer scaffolds seeded with neural stem cells in a canine spinal cord injury model. Cytotherapy 2010, 12:841-845.
36. Ryu H.H., Lim J.H., Byeon Y.E., Park J.R., Seo M.S., Lee Y.W., et al. Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. JVet Sci 2009, 10:273-284.
37. Xiao J., Wong A.W., Willingham M.M., van den Buuse M., Kilpatrick T.J., Murray S.S. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neuro-Signals 2010, 18:186-202.
38. van den Brand R., Heutschi J., Barraud Q., DiGiovanna J., Bartholdi K., Huerlimann M., et al. Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science 2012, 336:1182-1185.